PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.195
+0.115 (10.65%)
Jun 1, 2026, 2:58 PM EDT - Market open
PDS Biotechnology Employees
PDS Biotechnology had 21 employees as of December 31, 2025. The number of employees decreased by 3 or -12.50% compared to the previous year.
Employees
21
Change (1Y)
-3
Growth (1Y)
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$1,588,362
Market Cap
66.70M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 21 | -3 | -12.50% |
| Dec 31, 2024 | 24 | -1 | -4.00% |
| Dec 31, 2023 | 25 | -1 | -3.85% |
| Dec 31, 2022 | 26 | 4 | 18.18% |
| Dec 31, 2021 | 22 | 7 | 46.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PMV Pharmaceuticals | 54 |
| Mereo BioPharma Group | 39 |
| Entera Bio | 22 |
| Edesa Biotech | 17 |
| ImageneBio | 17 |
| Instil Bio | 17 |
| MiNK Therapeutics | 15 |
| Cingulate | 14 |
PDSB News
- 19 days ago - PDS Biotechnology Earnings Call Transcript: Q1 2026 - Transcripts
- 19 days ago - PDS Biotechnology Earnings release: Q1 2026 - Filings
- 19 days ago - PDS Biotechnology Quarterly report: Q1 2026 - Filings
- 19 days ago - PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update - GlobeNewsWire
- 26 days ago - PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results - GlobeNewsWire
- 5 weeks ago - PDS Biotechnology Registration statement: Registration filing - Filings
- 5 weeks ago - PDS Biotechnology Slides: Corporate presentation - Filings
- 6 weeks ago - PDS Biotechnology announces positive Phase 2 trial data for PDS01ADC - TheFly